GALLANZ Trademark

Trademark Overview


On Monday, August 7, 2017, a trademark application was filed for GALLANZ with the United States Patent and Trademark Office. The USPTO has given the GALLANZ trademark a serial number of 87558654. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 15, 2021. This trademark is owned by Novartis AG. The GALLANZ trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
gallanz

General Information


Serial Number87558654
Word MarkGALLANZ
Filing DateMonday, August 7, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2017

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Tuesday, February 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 27, 2020EXTENSION 5 GRANTED
Saturday, July 4, 2020EXTENSION 5 FILED
Thursday, July 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, July 4, 2020TEAS EXTENSION RECEIVED
Thursday, January 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 7, 2020EXTENSION 4 GRANTED
Tuesday, January 7, 2020EXTENSION 4 FILED
Tuesday, January 7, 2020TEAS EXTENSION RECEIVED
Wednesday, July 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2019EXTENSION 3 GRANTED
Monday, July 8, 2019EXTENSION 3 FILED
Monday, July 8, 2019TEAS EXTENSION RECEIVED
Wednesday, January 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019EXTENSION 2 GRANTED
Monday, January 7, 2019EXTENSION 2 FILED
Monday, January 7, 2019TEAS EXTENSION RECEIVED
Saturday, July 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 5, 2018EXTENSION 1 GRANTED
Thursday, July 5, 2018EXTENSION 1 FILED
Thursday, July 5, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 29, 2017ASSIGNED TO EXAMINER
Thursday, August 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 10, 2017NEW APPLICATION ENTERED IN TRAM